Explore

Trendline Trendline
XL-protein Launches PASylANTA Therapeutics to Develop Long-Acting IL-1Ra Biobetters for Disease Management

XL-protein Launches PASylANTA Therapeutics to Develop Long-Acting IL-1Ra Biobetters for Disease Management

XL-protein Launches PASylANTA Therapeutics to Develop Long-Acting IL-1Ra Biobetters for Disease Management
Rapid Read Rapid Read
Disney and Philips Collaborate to Launch Themed MRI Scanners for Children

Disney and Philips Collaborate to Launch Themed MRI Scanners for Children

Disney has partnered with Philips to introduce themed MRI scanners designed to comfort children undergoing imaging procedures. The collaboration integrates Disney's stories and characters into Philips Ambient Experience for MRI, creating an immersive environment aimed at reducing anxiety for young patients. The scanners feature themes from Mickey Mouse, Marvel superheroes, and Star Wars, among others. Clinical studies conducted in Europe have demonstrated significant reductions in stress levels and scan pauses among pediatric patients aged 6 to 10, highlighting the effectiveness of this approach. The initiative is set to expand to medical facilities across 87 countries, including the U.S., providing a more calming experience for children during scans.
Trendline Trendline
Cardiologist Warns Against 'Toxic' Foods for Children's Heart Health

Cardiologist Warns Against 'Toxic' Foods for Children's Heart Health

Cardiologist Warns Against 'Toxic' Foods for Children's Heart Health
Trendline Trendline
FDA Initiates Priority Review for Sanofi's Gaucher Disease Drug Venglustat

FDA Initiates Priority Review for Sanofi's Gaucher Disease Drug Venglustat

FDA Initiates Priority Review for Sanofi's Gaucher Disease Drug Venglustat
Trendline Trendline
PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member

PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member

PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member
AP News AP News
US adult cigarette smoking rate hits another all-time low

US adult cigarette smoking rate hits another all-time low

The cigarette smoking rate among U.S. adults dropped to another all-time low last year
Trendline Trendline
Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment

Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment

Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment
Rapid Read Rapid Read
American Cancer Society Recommends Blood Testing for Colorectal Cancer Screening to Address Rising Cases

American Cancer Society Recommends Blood Testing for Colorectal Cancer Screening to Address Rising Cases

The American Cancer Society has updated its guidelines to include blood testing as a screening option for colorectal cancer. This decision aims to increase screening rates, particularly among younger populations, as colorectal cancer has become the leading cause of cancer deaths among people under 50 in the United States. The new blood test, known as the Shield test, detects tumor DNA in the blood and is recommended for adults aged 45 and older who are at average risk and have not completed or declined other screening methods like colonoscopies or stool tests. Despite its lower sensitivity in detecting precancerous polyps compared to other methods, the blood test offers a less invasive option for those unwilling or unable to undergo traditional screenings.
Rapid Read Rapid Read
American Cancer Society Recommends Blood Test for Colorectal Cancer Screening

American Cancer Society Recommends Blood Test for Colorectal Cancer Screening

The American Cancer Society has updated its guidelines to include a blood test as a screening option for colorectal cancer. This new recommendation aims to provide an alternative for adults aged 45 and older who are at average risk and have declined traditional visual or stool-based tests. The Shield test, developed by Guardant Health and approved by the FDA in 2024, detects tumor DNA in the blood with 83% sensitivity for colorectal cancer. However, it is less effective at identifying precancerous polyps. The inclusion of blood testing is intended to increase screening rates, as colorectal cancer has become the leading cancer killer among U.S. adults under 50.
Rapid Read Rapid Read
Aalto University Develops Laser Heat Treatment to Combat Age-Related Macular Degeneration

Aalto University Develops Laser Heat Treatment to Combat Age-Related Macular Degeneration

Researchers at Aalto University have developed a new laser heat treatment aimed at combating the dry form of age-related macular degeneration (AMD), a condition affecting millions of Americans over 40. The treatment involves using near-infrared light to gently warm the tissue at the back of the eye, activating natural repair systems without causing harm. This approach targets the early stages of AMD, aiming to strengthen the protective mechanisms inside eye cells before significant damage occurs. The method has shown promise in animal studies, and human trials are set to begin in Finland in 2026 to assess safety and efficacy.
Trendline Trendline
Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment
Trendline Trendline
Retired Engineer Shares Longevity Habits After Pioneering Heart Treatment

Retired Engineer Shares Longevity Habits After Pioneering Heart Treatment

Retired Engineer Shares Longevity Habits After Pioneering Heart Treatment